In addition, correlation analysis between CASC9 expression and the clinicopathological characteristics of CRC implied that CASC9 overexpression was related to the TNM stage (Table 1), and the CASC9 expression level was higher in stages III–IV than in stages I–II (Fig. 1c). The gene discussed is CASC9; the disease is colorectal carcinoma.